14.4
Alzamend Neuro, Inc.
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26
Assets
(positive)
Change from FY22 to FY26
millions USD
FY22:
FY23:
5.84
FY24:
0.46
FY25:
4.18
FY26:
1.76
(positive)
Change from FY22 to FY26
millions USD
FY22:
0.10
FY23:
0.08
FY24:
0.18
FY25:
0.43
FY26:
0.31
Total assets
Change from FY22 to FY26
millions USD
FY22:
14.5
FY23:
5.92
FY24:
0.63
FY25:
4.60
FY26:
2.08
Liabilities & Equity
(negative)
Change from FY22 to FY26
millions USD
FY22:
1.16
FY23:
2.87
FY24:
3.23
FY25:
0.63
FY26:
1.35
(negative)
millions USD
FY22:
0
FY23:
0
FY24:
0
FY25:
0
FY26:
0
(positive)
Change from FY22 to FY26
millions USD
FY22:
13.4
FY23:
3.05
FY24:
−2.59
FY25:
3.97
FY26:
0.73
Total liabilities & equity
Change from FY22 to FY26
millions USD
FY22:
14.5
FY23:
5.92
FY24:
0.63
FY25:
4.60
FY26:
2.08
All amounts in millions USD